Advanced treatments. Backed by experience.
Our team of specialists treat all types of pituitary tumors and related conditions. PNI director and neurosurgeon Dr. Daniel Kelly has one of the most extensive endoscopic pituitary surgical experiences world-wide. We strive to get it right the first time, leading to shorter hospital stays, and better long-term outcomes.
A Collaborative Approach to Care
Pituitary tumors are complex in their diagnosis and treatment, requiring a team approach. We literally wrote the book on Pituitary Centers of Excellence, allowing our patients to be evaluated and treated by specialists in endocrinology, neurosurgery, neuro-ophthalmology and, ENT, typically in one visit.
A Fresh Perspective on Pituitary Tumors & Hormonal Health
We treat patients with the most challenging of pituitary and skull base tumors, including many with prior surgery and other treatments. We routinely provide second opinions and a safe surgical option for patients deemed “non-operative” elsewhere.
Get a Second Opinion
If you live in the United States outside Greater Los Angeles or are living abroad, our physicians can promptly review your imaging studies and other tests, and provide a recommendation on treatment options.Contact us today to schedule a consultation
Pacific Pituitary Disorders Center News, Healthy Living and Education
Pacific Neuroscience Institute Physicians Named “L.A.’s Top Doctors” of 2021
This year, seven of Pacific Neuroscience Institute Medical Group’s physicians were included in Los Angeles Magazine’s April 2021 roster of “L.A.’s Top Doctors.” The results were based on a Los Angeles Magazine survey that asked physicians throughout Los Angeles County to identify the doctors they considered to be…
Cushing’s Disease Helped Shape My Wonderful Life
Now twenty-one years in remission from a pituitary adenoma tumor, Sharmyn McGraw, patient advocate, author, artist, and so much more, talks about the pivotal role of Cushing’s disease in her life. From dyslexia to writer and everything in between. Dealing with a life threatening disease,…
PNI Founders’ Message 2021
Although our medical community continues to strain under the burden of COVID-19, there has been hope, determination and progress. Neurological diseases do not stop and neither have we at Pacific Neuroscience Institute.
Clinical Trials Round-Up: December 2020
New Studies Blue Earth Diagnostics FLC-219: (PDF): An Open-label, Single-arm, Single-dose, Prospective, Multicenter Phase 2b Study to Establish Image Interpretation Criteria for 18F-Fluciclovine Positron Emission Tomography (PET) in Detecting Recurrent Brain Metastases After Radiation Therapy (PURSUE) (NCT04410367) Actively Recruiting Studies Brain Cancer (Primary) – Glioma Aadi Bioscience (PDF): A…